↓ Skip to main content

Dove Medical Press

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability

Overview of attention for article published in Drug Design, Development and Therapy, July 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
27 Mendeley
Title
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
Published in
Drug Design, Development and Therapy, July 2021
DOI 10.2147/dddt.s317382
Pubmed ID
Authors

Xin Zhou, Zhuo Chen, Xinling Bi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 19%
Student > Ph. D. Student 2 7%
Researcher 2 7%
Lecturer 1 4%
Other 1 4%
Other 1 4%
Unknown 15 56%
Readers by discipline Count As %
Medicine and Dentistry 3 11%
Nursing and Health Professions 2 7%
Immunology and Microbiology 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Social Sciences 1 4%
Other 1 4%
Unknown 18 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2023.
All research outputs
#3,527,480
of 25,392,582 outputs
Outputs from Drug Design, Development and Therapy
#199
of 2,269 outputs
Outputs of similar age
#80,857
of 453,590 outputs
Outputs of similar age from Drug Design, Development and Therapy
#9
of 59 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,590 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.